Breast Cancer Drug Shows New Promise for Treatment
Posted on: Wednesday, 27 April 2005, 06:00 CDT
SAN FRANCISCO -- A drug that has been used to help the sickest breast cancer patients now shows promise in treating women in the early stages of a virulent type of the disease, the National Cancer Institute said Monday.
"This is a major advance for many thousands of women with breast cancer," said Dr. Andrew von Eschenbach, NCI's director.
The biotechnology company Genentech Inc., which makes the drug Herceptin, said it will discuss with federal regulators the possibility of prescribing the drug for more breast cancer patients.
In two human experiments that spanned five years and included more than 5,000 volunteers, the drug -- when given with chemotherapy -- extended the life expectancy of women who have a genetic mutation that shows up in about 30 percent of breast cancer cases.
Tumors in women given Herceptin were 52 percent less likely to recur.
Source: Cincinnati Post
Related Articles
- NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines
- Love/Avon Army of Women Breast Cancer Research Initiative to Launch Today
- St. Louis Cancer and Breast Institute to Get New AccuBoost System for Breast Cancer
- Use of Sequenom's MassARRAY System Leads to Significant Scientific Advances in Understanding Cancer, Diabetes and Drug-Resistant Malaria
- Bitter Defeat for Breast Cancer Victim Over Drug Postcode Lottery
- Breast Cancer Treatment Touted ; Drug Useful Against Early-Stage Disease
- New Breast Drug Will Help 1,000 Women to Beat Cancer
- Research and Markets: Clinical Trials Have Shown the Lack of Activity of Estramustine in Hormone Refractory Prostate Cancer, But the Drug Is Still Commonly Used Because of the Lack of Alternatives
- Breast Cancer Breakthrough: Past Drugs
- MAJOR WEAPON 'Lifeline' for Sufferers of Breast Cancer As New Drug Approved
 |
 |
User Comments (0)
RSS Feeds